E2F6 (E2F Transcription Factor 6) is a member of the E2F family of transcription factors that play critical roles in regulating cell cycle progression, gene expression, and cellular differentiation. Unlike other E2F family members that primarily function as transcriptional activators or repressors of cell cycle genes, E2F6 possesses unique structural features that enable it to act as a specialized transcriptional repressor involved in chromatin remodeling and gene silencing.
The E2F6 protein is encoded by the E2F6 gene located on chromosome 2p25.1. It contains a DNA-binding domain characteristic of E2F transcription factors but lacks the canonical transcriptional activation domain found in other E2F proteins. This structural difference underpins E2F6's specialized function as a transcriptional repressor and its involvement in chromatin-based gene silencing mechanisms.
E2F6's role in cell cycle regulation and gene silencing has significant implications for Alzheimer's disease and Parkinson's disease. Dysregulation of cell cycle control in neurons is a recognized feature of neurodegenerative diseases, and E2F6 may contribute to both protective and pathogenic processes.
The E2F6 protein consists of several functional domains that mediate its unique functions. The N-terminal region contains a DNA-binding domain consisting of a helix-loop-helix (HLH) motif that recognizes the E2F consensus DNA sequence TTTSSCGC (where S = G or C). This domain allows E2F6 to bind to promoter regions of target genes[1].
Unlike other E2F family members, E2F6 lacks a canonical transactivation domain and instead contains motifs that mediate interaction with chromatin-modifying complexes. The C-terminal region is involved in dimerization with other E2F proteins, allowing E2F6 to form heterodimers that can regulate gene expression.
E2F6 employs multiple mechanisms to repress gene expression[2]:
Direct DNA Binding: E2F6 can bind directly to E2F-responsive elements in promoter regions, blocking the binding of activating E2F proteins.
Polycomb Recruitment: E2F6 interacts with Polycomb group (PcG) proteins to establish repressive chromatin marks (H3K27me3) at target genes[3].
Histone Deacetylase Recruitment: E2F6 recruits HDAC complexes to remove acetyl groups from histones, promoting chromatin compaction.
DNA Methylation Interaction: E2F6 cooperates with DNA methylation machinery to maintain long-term gene silencing.
These mechanisms allow E2F6 to regulate genes independently of cell cycle control, making it particularly important in post-mitotic cells like neurons.
E2F6 is widely expressed in human tissues, with highest expression in the brain, testes, and embryonic tissues. In the brain, E2F6 is expressed in both neuronal and glial populations, with particular abundance in regions of active neurogenesis and synaptic remodeling.
During development, E2F6 plays critical roles in regulating neurogenesis[4]:
E2F6 influences synaptic development through its effects on gene expression:
In the adult brain, E2F6 continues to regulate neurogenesis in the subventricular zone and hippocampal subgranular zone[5]. It helps maintain the balance between neural stem cell proliferation and differentiation.
In mature neurons, E2F6 contributes to synaptic plasticity[6]:
A key mechanism by which E2F6 may influence neurodegeneration is through cell cycle control[7]:
E2F6 is relevant to AD pathogenesis through multiple mechanisms[8]:
Emerging evidence links E2F6 to PD[10]:
E2F6 may also play a role in ALS:
E2F6's role in chromatin remodeling has implications for neurodegeneration[11]:
E2F6 participates in the DNA damage response[12]:
E2F6 dysfunction may contribute to cellular senescence in neurodegeneration[14]:
E2F6 represents a potential therapeutic target[15]:
E2F6 expression and variants may serve as biomarkers:
Several challenges must be addressed:
Key questions remaining about E2F6 include:
The E2F transcription factor family: key regulators of cell cycle and disease. Cell Cycle. 2019. ↩︎
E2F6 is a transcriptional repressor that regulates cell cycle progression. Journal of Biological Chemistry. 2010. ↩︎
E2F6 cooperates with Polycomb proteins in transcriptional silencing. Molecular Cell. 2008. ↩︎
E2F transcription factors in neural development. Developmental Biology. 2017. ↩︎
Cell cycle regulation in adult neurogenesis. Stem Cells. 2018. ↩︎
E2F transcription factors in synaptic plasticity and memory. Learning & Memory. 2018. ↩︎
Cell cycle reactivation in neurons: a pathway to degeneration or protection. Nature Reviews Neuroscience. 2019. ↩︎
Cell cycle proteins in neuronal death and Alzheimer's disease. Journal of Alzheimer's Disease. 2018. ↩︎
Cell cycle abnormalities and tau pathology in Alzheimer's disease. Acta Neuropathologica. 2020. ↩︎
Cell cycle dysregulation in Parkinson's disease models. Molecular Neurobiology. 2021. ↩︎
Epigenetic regulation by E2F transcription factors in the brain. Brain Research. 2019. ↩︎
DNA damage response and cell cycle control in neurodegeneration. Neurobiology of Aging. 2020. ↩︎
E2F6 negatively regulates p53 in DNA damage response. Cell Death & Differentiation. 2011. ↩︎
Cellular senescence in neurodegeneration: role of cell cycle regulators. Aging Cell. 2020. ↩︎
Targeting cell cycle proteins for neurodegeneration therapy. Trends in Pharmacological Sciences. 2022. ↩︎